Cargando…
Integration of an EEG biomarker with a clinician's ADHD evaluation
BACKGROUND: This study is the first to evaluate an assessment aid for attention-deficit/hyperactivity disorder (ADHD) according to both Class-I evidence standards of American Academy of Neurology and De Novo requirements of US Food and Drug Administration. The assessment aid involves a method to int...
Autores principales: | Snyder, Steven M, Rugino, Thomas A, Hornig, Mady, Stein, Mark A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356845/ https://www.ncbi.nlm.nih.gov/pubmed/25798338 http://dx.doi.org/10.1002/brb3.330 |
Ejemplares similares
-
Treatment of adult ADHD: Is current knowledge useful to clinicians?
por: Torgersen, Terje, et al.
Publicado: (2008) -
Genetics of ADHD: What Should the Clinician Know?
por: Grimm, Oliver, et al.
Publicado: (2020) -
Indications for an EEG in a Child with ADHD
por: Millichap, J. Gordon, et al.
Publicado: (2015) -
A review of modafinil film-coated tablets for attention-deficit/hyperactivity disorder in children and adolescents
por: Rugino, Thomas
Publicado: (2007) -
Semi-Automated Biomarker Discovery from Pharmacodynamic Effects on EEG in ADHD Rodent Models
por: Yokota, Tatsuya, et al.
Publicado: (2018)